Covidien updates on pharma spinout

November 27, 2012 by MassDevice staff

Covidien updates investors on the planned spinout of its pharmaceuticals business, expected by mid-2013.


With strong fiscal 2012 numbers under its belt, Covidien (NYSE:COV) updated investors today on its expected financials after it spins out its pharmaceuticals business next year.

The Mansfield, Mass.-based medical device company said late last year that it planned to ditch the no-or-low-growth pharma unit, which will become a stand-alone operation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.